Accel Wealth Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
RC
PIM
WHG
Accel Wealth Management's AVNS Position: Q2 2023 in Review
Accel Wealth Management sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 28 shares — an estimated $833 sold.
Accel Wealth Management first reported a position in AVNS in Q4 2021 and held it in 6 quarters. The position peaked at $1.11K in Q4 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.
- Accel Wealth Management reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
- Accel Wealth Management sold 28 Avanos Medical shares in Q2 2023, an estimated $833.
- Accel Wealth Management first reported a position in Avanos Medical in Q4 2021 and held it in 6 quarters.
- Accel Wealth Management's Avanos Medical position peaked at $1.11K in Q4 2022.
- 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.
Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.